Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP26A1 | O43174 | 10/20 | 0.57 |
| ▸ | RARB | P10826 | 4/20 | 0.57 |
| ▸ | RARG | P13631 | 4/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | RARA | P10276 | 2/20 | 0.57 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.57 |
| ▸ | CYP26B1 | Q9NR63 | 8/20 | 0.47 |
| ▸ | RXRA | P19793 | 4/20 | 0.45 |
| ▸ | RXRB | P28702 | 4/20 | 0.45 |
| ▸ | RXRG | P48443 | 4/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9264079 | 0.87 | CYP26A1 (0.54) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL24410699 | 0.85 | RARB (0.71) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL9266634 | 0.85 | CYP26A1 (0.60) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL9257896 | 0.80 | CYP26A1 (0.46) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL9267411 | 0.80 | CYP26A1 (0.54) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL19342945 | 0.80 | RARG (0.56) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL19342983 | 0.79 | CYP3A4 (0.59) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL9265639 | 0.78 | RARB (0.44) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL9257747 | 0.76 | CYP26A1 (0.55) | CYP26A1RARBRARGCYP3A4RARA | |
| SCHEMBL31756569 | 0.76 | RARG (0.65) | CYP26A1RARBRARGCYP3A4RARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5466690-A | Treating psoriasis | ALLERGAN, INC. (US) | 1995-11-14 | — | — | US | disclosed |
| US-5354776-A | Treating psoriasis | ALLERGAN, INC. (US) | 1994-10-11 | — | — | US | disclosed |
| EP-0284261-B1 | Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity | ALLERGAN INC (US) | 1994-01-05 | — | — | EP | disclosed |
| US-5246962-A | Psoriasis, skin disorders | ALLERGAN, INC. (US) | 1993-09-21 | — | — | US | disclosed |
| US-5149705-A | Treatment of psoriasis | ALLERGAN, INC. (US) | 1992-09-22 | — | — | US | disclosed |
| EP-0284261-A1 | Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity | ALLERGAN, INC (US) | 1988-09-28 | — | — | EP | disclosed |